Marti’s Wish
Marti’s Wish supports faculty researchers studying biological mechanisms relevant to signet ring cell carcinoma, funding pilot work to advance research on tumor biology, metastasis, and treatment resistance.
Browse similar grants
Funder: Medical University of South Carolina
Due Dates: November 3, 2026 (Applications open) | February 26, 2027 (Application deadline)
Funding Amounts: Up to $50,000 for 12 months
Summary: Supports pilot research on biological mechanisms relevant to signet ring cell carcinoma, including metastasis, tumor biology, biomarkers, and treatment resistance.
Key Information: Studies may address any cancer type but must demonstrate clear relevance to signet ring cell carcinoma.
Description
Marti’s Wish is a pilot research award offered through the Medical University of South Carolina’s Hollings Cancer Center. It supports studies of biological mechanisms relevant to signet ring cell carcinoma, with priorities including metastasis, tumor biology, biomarker development, and treatment resistance. Research may focus on any cancer type if its relevance to signet ring cell carcinoma is clear.
The award builds on the Marti’s Wish Fund, established in 2016 through Harry Parnell’s commitment to cancer research in honor of his late wife, Marti. The fund supports research, education, and outreach in gastrointestinal cancers, particularly signet ring cell carcinoma and H. pylori-associated cancers. Hollings’ intramural funding opportunities seek to catalyze promising cancer research, foster interdisciplinary collaboration and translational research, and support work aligned with its strategic priorities and potential for future extramural funding.
